Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241771 · ClinicalTrials.gov registry record · NA
Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT03241771 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 325 participants.
The verdict
NCT03241771, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
In the setting of naloxone standing orders, this study will assess if direct outreach with a web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT) changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone
Interventions
- BEHAVIORAL Naloxone Navigator 1.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03241771
The ClinicalTrials.gov registry entry for NCT03241771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naloxone Navigator 1.0 is the first listed.
NCT03241771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03241771 about?
NCT03241771 is a clinical study titled "Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders". In the setting of naloxone standing orders, this study will assess if direct outreach with a web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT) changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone
What is the current status of trial NCT03241771?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2017-08-14. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03241771?
The interventions under investigation include: Naloxone Navigator 1.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03241771?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.